Human intestinal microbiota and type 1 diabetes

Current Diabetes Reports

Volumn 13, Issue 5, 2013, Pages 601-607

  Vaarala, Outi ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Akkermansia; Bacteroides; Beta cell autoantibodies; Bifidobacteria; Clostridium; Human intestinal microbiota; Type 1 diabetes

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; BUTYRIC ACID; INTERLEUKIN 10; LACTIC ACID; SHORT CHAIN FATTY ACID;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; BACTERIAL TRANSLOCATION; BACTEROIDETES; BIFIDOBACTERIUM; CLOSTRIDIUM; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; FECES MICROFLORA; FERMENTATION; HUMAN; IMMUNOMODULATION; IMPAIRED GLUCOSE TOLERANCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; NONHUMAN; REGULATORY T LYMPHOCYTE;

BACTERIA; BIODIVERSITY; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOMODULATION; INTESTINES; MICROBIOTA;

EID: 84884590309     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0409-5     Document Type: Article

References (39)

1. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555-62.
2. Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia. 2006;49:2824-7.
3. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol. 2008;24:701-6.
4. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes. 2003;52:2287-95.
5. Auricchio R, Paparo F, Maglio M, Franzese A, Lombardi F, Valerio G, et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes. 2004;53:1680-3.
6. Tiittanen M, Westerholm-Ormio M, Verkasalo M, Savilahti E, Vaarala O. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol. 2008;152:498-507.
7. Badami E, Sorini C, Coccia M, Usuelli V, Molteni L, Bolla AM, et al. Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes. 2011;60:2120-4.
8. Luopajärvi K, Savilahti E, Virtanen SM, Ilonen J, Knip M, Akerblom HK, et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes. 2008;9:434-41.
9. •• Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82-91. The findings of this pilot study including 4 healthy individuals and 4 children who developed type 1 diabetes suggest type 1 diabetes associated differences in the intestinal microbiota.
10. •• Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;610:e25792. The findings of this pilot study including 4 healthy individuals and 4 children who developed type 1 diabetes suggest that alterations in the metabolic potential of the microbiota is seen in type 1 diabetes.
11. •• Goffau M, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62:1238-44. This study demonstrates low abundance of butyrate producing bacteria and increased abundance of Bacteroides in prediabetic individuals providing a link to dysregulation of gut immune system and altered microbiota in type 1 diabetes.
12. • Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107:12204-9. This study describes Bacteroides fragilis and its polysaccharide A as inducer of intestinal regulatory T-cell development and regulator of colitis.
13. • Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 2010;185:4101-8. This article provides evidence of extra-intestinal immunological effects of commensals.
14. • Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337-41. This study demonstrates the induction of regulatory T-cells by Clostridium species and the long-lasting immunomodulatory effects of the oral administration with these Clostridium species at early life in a mouse model.
15. Nagano Y, Itoh K, Honda K. The induction of Treg cells by gut-indigenous Clostridium. Curr Opin Immunol. 2012;24:392-7.
16. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485-98.
17. • Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. PLoS One. 2010;5:e10507. doi: 10.1371/journal.pone. 0010507. This study identifies Lactobacillus johnsonii as an up-regulator of the intestinal IL-17 expression.
18. Knip M, Virtanen SM, Seppä K, Ilonen J, Savilahti E, Vaarala O, et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med. 2010;363:1900-8.
19. Vaarala O, Ilonen J, Ruohtula T, Pesola J, Virtanen SM, Härkönen T, et al. Removal of bovine insulin from cow's milk formula and early initiation of beta-cell autoimmunity in the FINDIA Pilot Study. Arch Pediatr Adolesc Med. 2012;166:608-14.
20. • Human Microbiome Project Consortium. Structure, function, and diversity of the healthy human microbiome. Nature. 2012;486:207-14. The extensive analyses of our microbiome indicate that the composition of gut microbiota also shows significant variation between healthy individuals.
21. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-4.
22. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of fecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-11.
23. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-94.
24. Romond MB, Colavizza M, Mullié C, Kalach N, Kremp O, Mielcarek C, et al. Does the intestinal bifidobacterial colonisation affect bacterial translocation? Anaerobe. 2008;14:43-8.
25. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia. 2006;49:2105-8.
26. Roesch LF, Lorca GL, Casella G, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 2009;3:536-48.
27. • Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339:1084-8. This study indicates that sex hormones modulate gut microbiota and vice versa and provides a novel link to hormone-dependent regulation of autoimmune diseases.
28. Hague A, Butt AJ, Paraskeva C. The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc. 1996;55:937-43.
29. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139:1619-25.
30. Li N, Hatch M, Wasserfall CH, Douglas-Escobar M, Atkinson MA, Schatz DA, et al. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? J Pediatr Gastroenterol Nutr. 2010;51:414-7.
31. Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol. 2002;68:5186-90.
32. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810-7.
33. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermidez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731-6.
34. Hansen CH, Krych L, Nielsen DS, Vogensen FK, Hansen LH, Sørensen SJ, et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia. 2012;55:2285-94. The findings of this study suggest that Akkermansia muciniphila could provide protection from autoimmune diabetes.
35. Oikarinen M, Tauriainen S, Oikarinen S, Honkanen T, Collin P, Rantala I, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 2012;61:687-91.
36. • Hara N, Alkanani AK, Ir D, Robertson CE, Wagner BD, Frank DN, et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J Immunol. 2012;189:3805-14. This paper demonstrates that viral infection caused change in the composition of the intestinal bacteria is a key determinant in the development of "virus induced autoimmune diabetes".
37. •• Cadwell K, Patel KK, Maloney NS, Liu T-C, NG ACY, Storer CE, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010;141:1135-45. The development of Crohn's disease resembling pathologies was demonstrated in a mouse model, in which toxin induced intestinal changes were dependent on the interaction of the disease related gene polymorphism, norovirus infection, commensal bacteria and activation of IFN-γ.
38. Visser JT, Bos NA, Harthoorn LF, Stellaard F, Beijer-Liefers S, Rozing J, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev. 2012;28:505-13.
39. Huovinen P. Bacteriotherapy: the time has come. BMJ. 2001;323:353-4.